Background: Chronic pouchitis with penetrating anal lesions often leads to pouch failure after restorative proctocolectomy. The aim of this study was to analyze those predictors and to evaluate the effects of infliximab (IFX). Methods: We reviewed patients' backgrounds and performed a prospective trial of IFX treatment. Possible pre-operative factors were analyzed. Efficacy was assessed by comparing the pouchitis disease activity index (PDAI) and peri-anal DAI. Long-term efficacy was assessed via the rate of pouch failure. Results: A total of 41 patients with refractory pouchitis were included. Although the patients with penetrating lesions were younger than those without, neither predictive pre-operative factors nor a correlation of C-related protein levels were observed. A total of 10 patients with penetrating lesions were enrolled for IFX treatment. Although the PDAI and peri-anal DAI decreased significantly (p = 0.04 and p = 0.02, respectively), the primary non-responders during the induction of IFX were 3 patients with obvious abscesses. The 1-year cumulative pouch failure rate was 0% in patients without abscesses and 50% in patients with abscesses under IFX maintenance. Conclusions: IFX treatment for refractory pouchitis with penetrating complications appears to be effective. However, once penetrating lesions develop to abscesses, these lesions are difficult to heal.

Keywords:
Ulcerative colitis, Pouchitis, Penetrating lesion, Infliximab, Pouch failure
1.
Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK: Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222:120-127.
2.
Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D: Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996;38:234-239.
3.
Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F: Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996;131:497-500; discussion 501-502.
4.
Ståhlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R: Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996;39:1012-1018.
5.
Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takesue Y, Tomita N: Clinical features and management of pouchitis in Japanese ulcerative colitis patients. Surg Today 2013;43:1049-1057.
6.
Belliveau P, Trudel J, Vasilevsky CA, Stein B, Gordon PH: Ileoanal anastomosis with reservoirs: complications and long-term results. Can J Surg 1999;42:345-352.
7.
Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH: Ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998;85:800-803.
8.
Foley EF, Schoetz DJ Jr, Roberts PL, Marcello PW, Murray JJ, Coller JA, Veidenheimer MC: Rediversion after ileal pouch-anal anastomosis. Causes of failures and predictors of subsequent pouch salvage. Dis Colon Rectum 1995;38:793-798.
9.
Körsgen S, Keighley MR: Causes of failure and life expectancy of the ileoanal pouch. Int J Colorectal Dis 1997;12:4-8.
10.
Lepistö A, Luukkonen P, Järvinen HJ: Cumulative failure rate of ileal pouch-anal anastomosis and quality of life after failure. Dis Colon Rectum 2002;45:1289-1294.
11.
MacRae HM, McLeod RS, Cohen Z, O'Connor BI, Ton EN: Risk factors for pelvic pouch failure. Dis Colon Rectum 1997;40:257-262.
12.
Fazio VW, Tekkis PP, Remzi F, Lavery IC, Manilich E, Connor J, Preen M, Delaney CP: Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg 2003;238:605-614; discussion 614-617.
13.
Haveran LA, Sehgal R, Poritz LS, McKenna KJ, Stewart DB, Koltun WA: Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA. Dis Colon Rectum 2011;54:15-20.
14.
Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF: Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994;69:409-415.
15.
Heuschen UA, Allemeyer EH, Hinz U, Autschbach F, Uehlein T, Herfarth C, Heuschen G: Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum 2002;45:776-786; discussion 786-788.
16.
Irvine EJ: Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 1995;20:27-32.
17.
Galandiuk S, Scott NA, Dozois RR, Kelly KA, Ilstrup DM, Beart RW Jr, Wolff BG, Pemberton JH, Nivatvongs S, Devine RM: Ileal pouch-anal anastomosis. Reoperation for pouch-related complications. Ann Surg 1990;212:446-452; discussion 452-454.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.